What medication challenges do Black persons with CKD have? Black persons with CKD experience pharmaco-inequities including lower initiation of new evidence-based medications for reducing CKD progression than White persons, and their risk for developing kidney failure is 3.4 times higher.
Black persons and health care providers whose practices are mainly comprised of Black persons with CKD will share their insights and possible solutions to these challenges.
We encourage you to take the course modules in order. Free CE: ACCME, ACPE, ANCC and Interprofessional Continuing Education Credit (IPCE).
This research was supported by the National Institutes of Health’s National Center for Advancing Translational Sciences, grant UL1TR002494.